MELODI
Multidisciplinary
European Low Dose Initiative
MELODI is a European Platform dedicated to low dose radiation risk research. In 2010 MELODI was founded as a registered association with 15 members.
The purpose of MELODI is:
EUROPE 2020 Strategy
Comunication with stakeholders
Cooperation with WHO and IAEA
News and Updates
MELODI SRA WG meeting summary – 11 May 2021
MELODI Strategic Research Agenda Working Group Meeting Summary – 11 May 2021 The MELODI SRA Working Group met on 11 May 2021 by web conference, this note provides a brief summary of discussions: Overview of MELODI activities and the evolving US low dose radiation...
In memorial of Wolfgang Weiss
It is with our deepest sorrow that we inform of the death of Wolfgang Weiss, the former Head of the Radiation Protection and Health Department at the Federal Office for Radiation Protection, Germany, the co-founder of MELODI and its first chair. Wolfgang significantly...
Workshop on Adverse Outcome Pathways (AOP) for radiation effects
Dear MELODI and ALLIANCE Colleagues, we are pleased to announce that a Workshop on Adverse Outcome Pathways (AOP) for radiation effects will be held from 12 to 16 April 2021 (every afternoon). The workshop is organized by the Institute of Radioprotection and...
More about MELODI
Based on the outcomes of the yearly MELODI workshops a Strategic Research Agenda (SRA) is being progressively developed. To assure an open and vivid discussion and development of the SRA the contribution from a large number of scientists and stakeholders is needed. More information about the SRA and the ongoing discussion can be found under SRA. Comments are welcome.
In parallel to the SRA a statement on a short- to medium-term research agenda for R&T projects is developed to improve the scientific basis for radiation protection in Europe giving guidance for pending EURATOM R&T project calls. These recommendations can be found under MELODI documents.